–
CP Group has invested US $ 515 million (approximately 15.4 billion baht) in exchange for a 15% stake in “Sinovac Lifesciences”, a Chinese manufacturer of “Coronavac” vaccine. Agreed to deliver to the country 2 million doses
On January 7, 2021, “Prachachat Business” compiled the following information about the COVID-19 vaccine, “Sinovac”:
- The vaccine is named “CoronaVac” (CoronaVac).
- The vaccine production process is that scientists use COVID-19 when cultivating a large number of the virus will destroy the activity or kill germs and then formulation with immune stimulants
- This vaccine uses the same principles as the hepatitis A vaccine, polio vaccine, rabies and many others.
- The Chinese authorities have not yet. Officially “approved use of the vaccine” But it is reported that China has already started vaccinating some of the population within the country.
- Experimental center “The Butanton Institute”, a biological research center and vaccine manufacturer. Brazil maintains that the vaccine is between 50-90% effective.
- Turkish researchers say the vaccine is 91.25% effective.
- Previously, the Indonesian vaccine company “Biopharma” said the vaccine was 97% effective, but later changed information that it was unable to determine.
- China has delivered 3 million doses of the vaccine to Indonesia by Indonesia’s President Joko Widodo. Be the first to be vaccinated on Jan. 13, the nationwide date of vaccination.
- The Philippines orders 25 million doses of the vaccine to arrive by March.
- The vaccine will arrive in Thailand 2 million doses, with the first 200,000 doses arriving at the end of February.
- Both Indonesia and the Philippines They brought the vaccine to test themselves. And waiting for approval of the use of emergency from domestic orders
–
